This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited.
If you do not agree, please click here.
Today we turn to you with news: Our new webshop is online!
Our customers benefit from a contemporary system that improves the comfort in the application. In addition to many updates and improvements the shop is now optimized for all digital devices (cellphones, tablets etc.).
Information for customers who already have an account
To continue logging in with your old account, you must reset or re-enter your password once. In this case please use the link “Forgotten password?”.
Provides an exhaustive review of the state of the art in the management of prostate cancer
Emphasizes a multidisciplinary approach
Explains the roles of the different therapies and active surveillance
Addresses diagnosis and clinical work-up in depth
Examines the value of individual and mass screening
This book, now in an extensively revised second edition, provides an exhaustive review of the state of the art in the management of prostate cancer, from screening to treatment, with emphasis on a multidisciplinary approach. The editors are very excited about the outstanding new or updated contributions from the different expert authors.
The opening chapters address basic aspects including epidemiology, pathology, biology, genetics, and chemoprevention. The role of individual and mass screening is carefully appraised, and extensive attention is devoted to diagnosis and clinical work-up by means of recently implemented investigations such as multiparametric MRI and choline PET-CT.
The use of active surveillance is examined in detail. Subsequent chapters discuss the different therapies that may be employed: open and minimally invasive, including robot-assisted, radical prostatectomy, the various forms of radiation treatment, high-intensity focused ultrasound, cryotherapy, hormonal manipulations, chemotherapy, targeted therapies, and immunotherapy. Up-to-date results from practice-changing phase III randomized clinical trials are included and special insights are provided into the interpretation of results and the patient’s perspective.